Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Efficacy and Safety Studies in One Email
-
Hello, if we wanted to prepare a promotional email for the representatives to send to HCPs that included both efficacy and safety claims in one email, is that permitted?
-
Hi @hrj2021,
Yes, efficacy and safety data that meets PAAB requirements may appear together in APS.
